EDAP TMS Stock (NASDAQ:EDAP)


ForecastRevenueOwnershipFinancialsChartTranscripts

Previous Close

$2.49

52W Range

$2.27 - $8.50

50D Avg

$2.72

200D Avg

$5.05

Market Cap

$91.65M

Avg Vol (3M)

$122.82K

Beta

0.38

Div Yield

-

EDAP Company Profile


EDAP TMS S.A., together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. It operates in three segments: High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution Services (DIST). The HIFU segment develops, manufactures, and markets medical devices based on HIFU technology for the minimally invasive treatment of urological and other clinical indications. This segment also offers Ablatherm, an ultrasound guided robotic HIFU device for the treatment of organ-confined prostate cancer; Ablatherm Fusion that incorporates the company's proprietary fusion software, which merges MRI and ultrasound images; and the Focal One, a HIFU robotic device dedicated to the focal therapy of prostate cancer, as well as disposables, and leasing and treatment related services; and maintenance services. The ESWL division manufactures, markets, and services lithotripter for the treatment of urinary tract stones by means of ESWL technology; and offers Sonolith i-move, an extracorporeal shockwave lithotripter to small and mid-size hospitals, as well as sells disposable parts for lithotripters and electrodes. The Distribution division markets, distributes, and services lasers, micro-ultrasound systems, and other medical products from third parties, as well as leases devices; sells disposables and spare parts; and offers maintenance services. The company markets and sells its products through its direct marketing, sales organization, and service platform, as well as through third-party distributors and agents. Its customers include hospitals, urology clinics, and research institutions. The company was incorporated in 1979 and is headquartered in Lyon, France.

Show More

Industry

Medical - Devices

Sector

Healthcare

Exchange

NASDAQ

ADR

Yes

Country

FR

Employees

307

IPO Date

Aug 01, 1997

Website

EDAP Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceDec 23Dec 22Dec 21
Goods---
Spare parts and services---
RPP's and leases---
Extension of Warranty---
Licenses and others.---
Service---

Fiscal year ends in Dec 23 | Currency in EUR

EDAP Financial Summary


Dec 23Dec 22Dec 21
Revenue---
Operating Income---
Net Income---
EBITDA---
Basic EPS---
Diluted EPS---

Fiscal year ends in Dec 23 | Currency in EUR

Latest Earnings Call Transcripts


Q2 24Aug 28, 24 | 11:30 AM
Q1 24May 16, 24 | 12:00 AM
Q4 23Mar 27, 24 | 11:32 AM

Peer Comparison


TickerCompany
ABCCencora
MCKMcKesson Corporation
OMIOwens & Minor, Inc.
PDCOPatterson Companies, Inc.
ZYXIZynex, Inc.
HSICHenry Schein, Inc.
CAHCardinal Health, Inc.